EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

TGF-β-Based Therapies for Treating Ocular Surface Disorders

Fernando T Ogata, Sudhir Verma iD, Vivien J Coulson-Thomas iD, Tarsis F Gesteira iD

Cells · 26.06.2024 · 13 (13) · 1105

DOI: 10.3390/cells13131105 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 26.06.2024. Verfasst von Fernando T Ogata und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Optometry, University of Houston, 4901 Calhoun Road, Houston, TX 77204, USA. Hauptthemen laut MEDLINE: Transforming Growth Factor beta, Wound Healing. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 192 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, National Institute of Health, Association for Research in Vision and Ophthalmology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cornea is continuously exposed to injuries, ranging from minor scratches to deep traumas. An effective healing mechanism is crucial for the cornea to restore its structure and function following major and minor insults. Transforming Growth Factor-Beta (TGF-β), a versatile signaling molecule that coordinates various cell responses, has a central role in corneal wound healing. Upon corneal injury, TGF-β is rapidly released into the extracellular environment, triggering cell migration and proliferation, the differentiation of keratocytes into myofibroblasts, and the initiation of the repair process. TGF-β-mediated processes are essential for wound closure; however, excessive levels of TGF-β can lead to fibrosis and scarring, causing impaired vision. Three primary isoforms of TGF-β exist—TGF-β1, TGF-β2, and TGF-β3. Although TGF-β isoforms share many structural and functional similarities, they present distinct roles in corneal regeneration, which adds an additional layer of complexity to understand the role of TGF-β in corneal wound healing. Further, aberrant TGF-β activity has been linked to various corneal pathologies, such as scarring and Peter’s Anomaly. Thus, understanding the molecular and cellular mechanisms by which TGF-β1-3 regulate corneal wound healing will enable the development of potential therapeutic interventions targeting the key molecule in this process. Herein, we summarize the multifaceted roles of TGF-β in corneal wound healing, dissecting its mechanisms of action and interactions with other molecules, and outline its role in corneal pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transforming Growth Factor betaWound HealingHumansAnimalsCorneal DiseasesCorneaSignal Transduction

Stichwörter der Autor:innen

TGF-β signaling pathwaycorneal wound healing

Substanzen

Transforming Growth Factor beta

Autor:innen und Institutionen

  • College of Optometry, University of Houston, 4901 Calhoun Road, Houston, TX 77204, USA.
  • Deen Dayal Upadhyaya College, University of Delhi, Delhi 110078, India.

ORCID-Profile: Sudhir Verma, Vivien J Coulson-Thomas, Tarsis F Gesteira

Förderung

  • NEI NIH HHS
  • National Institute of Health
  • Association for Research in Vision and Ophthalmology
  • University of Houston
  • National Institute of Health/National Eye Institute

Zitieren

APA

Ogata, F. T., Verma, S., Coulson-Thomas, V. J., & Gesteira, T. F. (2024). TGF-β-Based Therapies for Treating Ocular Surface Disorders. Cells, 13(13), 1105. https://doi.org/10.3390/cells13131105

Vancouver

Ogata FT, Verma S, Coulson-Thomas VJ, Gesteira TF. TGF-β-Based Therapies for Treating Ocular Surface Disorders. Cells. 2024;13(13):1105. doi:10.3390/cells13131105

BibTeX
@article{Ogata2024,
  author = {Ogata, Fernando T and Verma, Sudhir and Coulson-Thomas, Vivien J and Gesteira, Tarsis F},
  title = {TGF-β-Based Therapies for Treating Ocular Surface Disorders},
  journal = {Cells},
  year = {2024},
  volume = {13},
  number = {13},
  pages = {1105},
  doi = {10.3390/cells13131105}
}
Kostenlos starten →